Can a Dual-Chamber device shrink an enlarged heart in AF patients?
NCT ID NCT01994252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 200 people with both heart failure and permanent atrial fibrillation. Participants received either a standard defibrillator (ICD) or one that also paces both lower heart chambers (CRT/ICD). The goal was to see if the extra pacing reduces heart size and improves pumping function, quality of life, and survival. The trial is now complete, and results will show whether this approach helps this specific group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Implantable cardioverter-defibrillator (ICD) with or without cardiac resynchronization therapy (CRT)
What this could lead to
If successful, this could show that biventricular pacing helps shrink an enlarged heart and improve pumping efficiency in heart failure patients with permanent atrial fibrillation.
What could go wrong
This is a completed trial with 200 participants, so results are available but may not apply to all patients. The benefit of CRT in atrial fibrillation is still debated, and device implantation carries risks like infection or lead problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHUM Centre hospitalier universitaire de Montréal
Montreal, Quebec, Canada
-
Hamilton Health Sciences
Hamilton, Ontario, Canada
-
Institut universitaire de cardiologie et de pneumologie de Quebec
Québec, Quebec, Canada
-
Kingston General Hospital
Kingston, Ontario, Canada
-
Le Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
-
Libin Cardiovascular Institute of Alberta
Calgary, Alberta, Canada
-
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
-
McGill Health Science Centre
Montreal, Quebec, Canada
-
Montreal Heart Institute
Montreal, Quebec, Canada
-
Queen Elizabeth II Health Science
Halifax, Nova Scotia, Canada
-
St. Boniface General Hospital
Winnipeg, Manitoba, Canada
-
St. Michael's General Hospital
Toronto, Ontario, Canada
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1W 4W7, Canada
-
Vancouver General Hospital
Vancouver, British Columbia, Canada
-
Victoria Cardiac Arrhythmia Trials
Victoria, British Columbia, V8R 4R2, Canada